TY - JOUR
T1 - Gray Matter Nucleus Hyperintensity after Monthly Triple-Dose Gadopentetate Dimeglumine with Long-term Magnetic Resonance Imaging
AU - Debevits, John J.
AU - Munbodh, Reshma
AU - Bageac, Devin
AU - Wu, Rong
AU - Dicamillo, Paul A.
AU - Hu, Chaoran
AU - Wang, Lihong
AU - Naismith, Robert T.
AU - Karimeddini, David
AU - Dhib-Jalbut, Suhayl
AU - Redko, Sviatoslav
AU - Cook, Stuart D.
AU - Cadavid, Diego
AU - Wolansky, Leo
N1 - Funding Information:
Received for publication October 31, 2019; and accepted for publication, after revi-sion, December 27, 2019. From the *University of Connecticut, School of Medicine, Farmington, CT; †Warren Alpert Medical School of Brown University, Providence, RI; ‡University of Iowa, Carver College of Medicine Iowa City, IA; §Washington University School of Medicine, St. Louis, MO; ||Rutgers University, New Jersey Medical School, Newark, NJ; and ¶University of Massachusetts Medical School, Worcester, MA. John J. DeBevits and Reshma Munbodh contributed equally to this project and are to be considered co–first authors. Conflicts of interest and sources of funding: This research was investigator-initiated. This retrospective study was funded by Guerbet. The original BECOME study was funded by Bayer. Correspondence to: Leo Wolansky, MD, Diagnostic Imaging & Therapeutics, UCONN School of Medicine, Room FM-086, 263 Farmington Ave, Farmington, CT 06030. E-mail: wolansky@uchc.edu. Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com). Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. ISSN: 0020-9996/20/5510–0629 DOI: 10.1097/RLI.0000000000000663
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Objectives Gadolinium deposition is widely believed to occur, but questions regarding accumulation pattern and permanence remain. We conducted a retrospective study of intracranial signal changes on monthly triple-dose contrast-enhanced magnetic resonance imaging (MRI) examinations from the previously published Betaseron vs. Copaxone in Multiple Sclerosis With Triple-Dose Gadolinium and 3-Tesla MRI Endpoints Trial (N = 67) to characterize the dynamics of gadolinium deposition in several deep brain nuclei and track persistence versus washout of gadolinium deposition on long-term follow-up (LTFU) examinations (N = 28) obtained approximately 10 years after enrollment in the Betaseron vs. Copaxone in Multiple Sclerosis With Triple-Dose Gadolinium and 3-Tesla MRI Endpoints Trial. Materials and Methods Using T2 and proton density images and using image analysis software (ITK-SNAP), manual regions of interest were created ascribing boundaries of the caudate nucleus, dentate nucleus, globus pallidus, pulvinar, putamen, white matter, and air. Intensity analysis was conducted on T1-weighted fat-saturated (fat-sat) images using the FSL package. A linear rigid-body transform was calculated from the fat-sat image at each target time point to the region of interest segmentation reference time point fat-sat image. Serial MRI signal was analyzed using linear mixed regression modeling with random intercept. Annual MRI signal changes including LTFU scans were assessed with t test. Results During monthly scanning, all gray matter structures demonstrated a significant (P < 0.0001) increase in contrast-to-noise ratio. Yearly changes in deposition showed distinctive patterns for the specific nucleus: globus pallidus showed complete retention, pulvinar showed partial washout, while dentate, caudate, and putamen returned to baseline (ie, complete washout). Conclusions Monthly increased contrast-to-noise ratio in gray matter nuclei is consistent with gadolinium deposition over time. The study also suggests that some deep gray matter nuclei permanently retain gadolinium, whereas others demonstrate washout of soluble gadolinium.
AB - Objectives Gadolinium deposition is widely believed to occur, but questions regarding accumulation pattern and permanence remain. We conducted a retrospective study of intracranial signal changes on monthly triple-dose contrast-enhanced magnetic resonance imaging (MRI) examinations from the previously published Betaseron vs. Copaxone in Multiple Sclerosis With Triple-Dose Gadolinium and 3-Tesla MRI Endpoints Trial (N = 67) to characterize the dynamics of gadolinium deposition in several deep brain nuclei and track persistence versus washout of gadolinium deposition on long-term follow-up (LTFU) examinations (N = 28) obtained approximately 10 years after enrollment in the Betaseron vs. Copaxone in Multiple Sclerosis With Triple-Dose Gadolinium and 3-Tesla MRI Endpoints Trial. Materials and Methods Using T2 and proton density images and using image analysis software (ITK-SNAP), manual regions of interest were created ascribing boundaries of the caudate nucleus, dentate nucleus, globus pallidus, pulvinar, putamen, white matter, and air. Intensity analysis was conducted on T1-weighted fat-saturated (fat-sat) images using the FSL package. A linear rigid-body transform was calculated from the fat-sat image at each target time point to the region of interest segmentation reference time point fat-sat image. Serial MRI signal was analyzed using linear mixed regression modeling with random intercept. Annual MRI signal changes including LTFU scans were assessed with t test. Results During monthly scanning, all gray matter structures demonstrated a significant (P < 0.0001) increase in contrast-to-noise ratio. Yearly changes in deposition showed distinctive patterns for the specific nucleus: globus pallidus showed complete retention, pulvinar showed partial washout, while dentate, caudate, and putamen returned to baseline (ie, complete washout). Conclusions Monthly increased contrast-to-noise ratio in gray matter nuclei is consistent with gadolinium deposition over time. The study also suggests that some deep gray matter nuclei permanently retain gadolinium, whereas others demonstrate washout of soluble gadolinium.
KW - contrast media
KW - gadolinium
KW - multiple sclerosis
UR - http://www.scopus.com/inward/record.url?scp=85090704566&partnerID=8YFLogxK
U2 - 10.1097/RLI.0000000000000663
DO - 10.1097/RLI.0000000000000663
M3 - Article
C2 - 32898355
AN - SCOPUS:85090704566
SN - 0020-9996
VL - 55
SP - 629
EP - 635
JO - Investigative Radiology
JF - Investigative Radiology
IS - 10
ER -